Other pulmonary heart/vessel disease


pulmonary arterial hypertension: Pulmonary arterial hypertension (PAH) is a group of diseases characterized by elevated pulmonary arterial resistance leading to right heart failure. PAH is progressive and potentially fatal. PAH may be idiopathic and/ or familial, or induced by drug or toxin (drug-or toxin-induced PAH, see these terms) or associated with other diseases like congenital heart disease, connective tissue disease, HIV, schistosomiasis, portal hypertension (PAH associated with other disease, see this term).

Endpoint definition

FinnGen phenotype data

321302 individuals

diagram downward connector

Apply sex-specific rule None


diagram downward connector

Check conditions None


diagram downward connector
diagram bullet

Filter registries

Hospital Discharge: ICD-10 I27, I28
Hospital discharge: ICD-9 416|417
Hospital discharge: ICD-8 426
Cause of death: ICD-10 I27, I28
Cause of death: ICD-9 416|417
Cause of death: ICD-8 426


diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9


diagram downward connector

Check minimum number of events None


diagram downward connector
diagram bullet diagram downward connector

Include endpoints


diagram downward connector

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 894 422 472
Unadjusted prevalence (%) 0.29 0.24 0.35
Mean age at first event (years) 64.05 62.05 65.84


Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence


Index endpoint: I9_PULMOTHHD – Other pulmonary heart/vessel disease
GWS hits: 0

Survival analyses between endpoints


before Other pulmonary heart/vessel disease
after Other pulmonary heart/vessel disease

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Other pulmonary heart/vessel disease